Emcure Pharmaceuticals' IPO, open from July 3 to July 5, saw a massive 67.84 times subscription on its final day. The ₹1,952 crore IPO included a fresh issue of ₹800 crore and an offer for sale (OFS) of 1.14 crore shares worth ₹1,152 crore by promoters and existing shareholders. Heavy participation came from qualified individual investors (QIBs), with their category getting subscribed 195.83 times. Non-institutional investors' portion saw 48.28 times subscription, while retail investors subscribed 7.18 times. The price range for the IPO was set between ₹960 and ₹1,008 per share.